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Abstract
The current neuronavigation techniques increase safety and surgeon confidence 
during neurosurgical procedure performance. However, its real usefulness remains 
in integrating multimodal information from advanced magnetic resonance imaging, 
as tractography (DTI), functional studies that evaluate motor and sensitive lan-
guage, motor function (BOLD techniques with different paradigms), and nuclear 
medicine. At the operating room, the fusion of sonographic information acquired 
in real-time with the predefined plan increase the chance to achieve gross-total 
resection of primary brain tumors. Combining these different image modalities 
with brain mapping and motor stimulation information in selected cases is possible, 
increasing surgery safety. In this review, we present our experience with multi-
modal neuronavigation to treat brain tumors in pediatric patients.
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1. Introduction
Gliomas are primary tumors of the central nervous system. They are derived 
from glial cells. They are the most common cause of solid tumors in the intracranial 
space in children [1]. Nearly 70,000 new cases of malignant primary and benign 
brain tumors of the central nervous system (CNS) are diagnosed in the United 
States each year. Of these, approximately 28% are gliomas, and 36% are meningio-
mas. Gliomas represent 80% of the primary malignant brain tumors. The incidence 
rates of brain tumors have increased in the last three decades. For all CNS tumors, 
of which brain tumors account for approximately 88%, the average annual inci-
dence rate adjusted for age (2006 to 2010) for women (22.8 per 100,000) is higher 
than for men (19.1 per 100,000) [1, 2].
According to the World Health Organization (WHO) classification of brain 
tumors, they are divided into gliomas of the low and high degree of malignancy. 
Low-grade gliomas - I and II, are represented by pilocytic astrocytoma, diffuse 
glioma, and gemistocytic astrocytoma. They have a benign clinical course with a 
long survival time. High-grade gliomas, anaplastic astrocytoma (grade III) and 
glioblastoma multiforme (grade IV), are characterized by a rapid growth rate, 
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extensive white matter infiltration, and poor short-term prognosis [3, 4]. Therefore, 
the histopathological diagnosis and its proper classification are crucial for treating 
patients. Diffuse astrocytoma (WHO grade II) is characterized by slow growth and 
infiltration of neighboring brain structures Figure 1 [5–7].
In pediatric patients, the central nervous system’s tumors represent the second 
cause of cancer mortality after leukemia. The magnetic resonance imaging tech-
nique renders the integration of different structural images (FLAIR, diffusion, 
perfusion, SPGR, TRUFFI), functional aspects (DTI, BOLD), and metabolic profile 
(spectroscopy). They evaluated peritumoral edema by diffusion and perfusion 
sequences [8, 9]. The use of sequences that provide functional information allows 
the early identification of the risks associated with neurosurgical treatment and 
each case’s functional prognosis [10]. Some reports show a characteristic uptake 
pattern for the degree of malignancy of different neoplasms. In the case of primary 
tumors of the CNS, significant alterations can be observed in the uptake of glucose, 
methionine, and tyrosine. One of the technological resources that have changed the 
treatment of patients with CNS neoplasms is neuronavigation.
2.  Characteristics of Magnetic Resonance Imaging Studies for 
Neuronavigation
The radiological evaluation of brain tumors makes it possible to identify the 
structural, functional, and metabolic characteristics of neoplastic lesions and, for 
prognostic purposes, their relationship with healthy brain tissue by combining 
diverse image acquisition techniques.
The MRI imaging modalities currently used in presurgical planning for brain 
tumor resection are functional magnetic resonance imaging (fMRI), diffusion 
tensioner (DTI) imaging, diffusion tension tractography, and BOLD [2].
2.1 Diffusion Tensor Images (DTI)
The diffusion tensor images allow the visualization and characterization of white 
matter tracts [11–13]. DTI images have been used to study the architecture of white 
matter and the integrity of normal and diseased brains. This magnetic resonance 
technique is based on the general principle that the anatomical microstructure 
directs water diffusion, being an echo-planar technique that maps the diffusion 
Figure 1. 
Intraoperative cerebral edema during emergency surgery in a patient with neurological deterioration secondary 
to a brain tumor bleeding.
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speed [14]. In brain tissue, diffusion rates are slower due to the typical parenchyma 
components that impede water movement. In specific pathological processes, water 
diffusion is restricted, which reduces the apparent diffusion coefficient (ADC), as 
in acute infarcts secondary to cytotoxic edema, abscess, lymphoma [12, 15]. Fiber 
tracking is the only non-invasive method to visualize the course, displacement, or 
interruption of white matter’s main tracts according to the DTI technique. Multiple 
studies have shown that fiber tracking can reconstruct white matter’s major fiber 
structures in the brain. Identifying the tracts is done by defining a rectangular 
interest volume (VOI) in the registered standard T1 anatomical datasets. A fast 
acquisition gradient echo sequence prepared with 3D magnetization weighted in T1 
is used to acquire the images. T2-weighted images are acquired, inversion recovery 
images attenuated by T2 fluid, and 3D images weighted in T1 postcontrast are 
scanned. Intraoperative examinations are performed immediately when the operator 
considers that the lesion has been resected or intraoperative exploration was neces-
sary to correct the cerebral displacement. For DTI, applies a sequence of echo-planar 
images weighted by spin-echo diffusion of a single shot (echo time, 147 millisec-
onds, repetition time, 9400 milliseconds, matrix size, 128 × 128, the field of view, 
251 × 251 mm, the thickness of cut, 3 mm, bandwidth, 1502 Hz per pixel, diffusion 
encoding gradients in 12 directions with b values of 0 and 1000 s/mm2, and voxel 
size, 1.9 × 1.9 × 3 mm) [12, 13, 16]. The 3D segmental reconstruction of the tumor is 
performed based on the high-resolution 3D postcontrast anatomical data set.
In the case of tumors with high uptake of contrast medium - glioblastoma mul-
tiforme, metastasis, the edge of the outermost lesion that enhances post-contrast, 
for example, glioblastoma, and the edge of hyperintensity or mixed hypointensity 
in the lesion, such as the non-malignant entity, cavernoma, represented the limit of 
segmentation. In non-enhancing lesions such as low-grade glioma, the T2-weighted 
image is used to determine the tumor’s edge. For this reason, most tumors that do 
not have post-contrast enhancement have optimal visibility in this sequence. The 
existence of significant edema, which cannot be clearly distinguished from the 
low-grade glioma, was ruled out based on the findings of inversion recovery images 
with T2 fluid. The segmentation of the tumor is performed by cutting in a mode of 
3D anatomical data. After profiling all the sections that contained the lesion, the 
three-dimensional reconstruction of the lesion was performed [13].
The techniques of DTI and tractography have overcome this obstacle and are now 
widely used to study the white matter in vivo. Diffusion images calculate the local 
direction of white matter from water diffusion measurements. Tractography takes this 
a step further to evaluate the functional connection between several different areas 
inside the same or contralateral hemisphere. The identification of water molecule’s 
movement in all directions is known as isotropic diffusion. In the central nervous 
system, anisotropic diffusion is used to define water’s movement in a parallel sense in 
the withe matter tracts defined by axons’ groups. Thus, creating maps of movement 
of water that define the structure and orientation of with matter tracts [2, 3].
Three-dimensional visualization of white substance fibers, such as the cortico-
spinal (pyramidal) tract, corpus callosum, cerebellar peduncles, optical radiation, 
and arcuate fascicle, is of great value at the preoperative evaluation and intraopera-
tive navigation Figure 2 [4].
2.2 Perfusion
There are three main techniques for perfusion imaging: T2 * enhanced 
dynamic magnetic susceptibility enhanced perfusion in T1-enhanced dynamic 
contrast, and arterial spin marking techniques, involving repetitive serial images 
through the tumor during blood passage been marked with contrast material. 
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Theoretically, the degree of a signal drop is proportional to the concentration 
of gadolinium in the tissue, obtaining relative curves of concentration - time. 
Dynamic contrast images weighted in T1, where the main focus is estimating 
tumor permeability, allow the contrast to filter into the extravascular space and 
reach equilibrium during multiple contrast bolus passes through the tumor bed. 
An arterial spin is a form of perfusion without the use of intravenous contrast; 
a powerful magnetic gradient is applied to the blood inlet to reverse the mag-
netization, effectively labeling the blood that flows upward, have impeded its 
application for long periods of imaging and decrease in spatial resolution com-
pared to gadolinium [16]. Different types of tumors and grades differ in their 
perfusion characteristics. For example, there is a strong correlation between the 
degree of astrocytoma and the relative measurements of cerebral blood volume 
(CBV) [17]. However, low-grade astrocytomas tend to have a high cerebral blood 
volume, associated with the process of angiogenesis and dense capillary net-
works that characterize these tumors.
2.3 Magnetic resonance spectroscopy
It provides an analysis of the different metabolites in a delimited area within 
the brain and may be useful in the initial diagnosis of brain tumors. It can be 
done with a single voxel technique, in which a single spectrum is produced for 
a tissue volume, or a multivoxel technique, in which a greater volume of tissue 
is evaluated [18]. The primary metabolites evaluated include N-acetyl aspartate 
(NAA) (typical neuronal marker), choline (cell membrane marker), creatine 
(energy marker), lactate (metabolic acidosis), and lipids (tissue breakdown and 
cell death). The spectral patterns of intracranial neoplasms vary significantly 
due to differences in tumor types and grades. However, most CNS tumors 
manifest with elevated choline-creatine and co-NAA ratios caused by increases 
in cellularity (choline elevation) and a relative decrease in normal neurons  
(reduction of NAA).
Figure 2. 
3D reconstructions for white matter tracts with DTI-MRI technique. (A) Thalamic high-grade glioma and his 
relationship with the pyramidal tract. (B) Parasagittal meningioma and its relationship with corpus callosum 
and pyramidal tract. (C) Supratentorial Ependymoma and its relations with Corpus callosum. (D) Fourth 
ventricle tumor and middle cerebellar peduncle displacement.
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2.4 Functional MRI Images
Functional MRI (fMRI) mapping of eloquent language cortex in patients with 
brain tumors after surgery is feasible and may serve as a useful reference assessment 
for preoperative neurosurgical planning [19].
Functional magnetic resonance imaging (MR) is an advanced tool for studying 
brain functions in healthy subjects and neuropsychiatric patients, identifying and 
locating specific metabolism and neural activity phenomena [20].
BOLD is a measure of changes in oxygenated and deoxygenated blood propor-
tion during a particular paradigm’s execution. The most commonly mapped func-
tions during functional MRI studies include motor, auditory, somatosensory, visual 
perception, and language production and comprehension. When evaluating motor 
centers, typical tasks include tapping with fingers, pouting with lips, and flexing 
and extending toes [21]. Patients with mild to severe motor paresis of the hand may 
clench their fists instead of tapping with their fingers.
Several reports mention that a silent area around a brain tumor could recover his 
eloquence after the surgical resection of malignant tissue [22]. There is a latency of 
several seconds in the signal change observed in BOLD images, making the tempo-
ral resolution of functional MRI poor compared to other techniques such as DES 
or electroencephalography [23]. Because of the “delay of hemodynamic response” 
given the time required for the production and diffusion of vascular signal 
Figure 3. 
The utility of fMRI and tractography for surgical planning. An 8-years-old boy presents at the emergency unit 
with a history of intermittent language disturbances and right-hemiparesis. fMRI (language paradigm) and 
DTI (Pyramidal tract, Corpus callous, Arcuate fascicle) images were performed. A 3D reconstruction at the 
Brainlab neuronavigation station was performed. (A) Pyramidal tract reconstruction and his relationship 
with a neoplastic lesion (Yellow) and language areas visualized with fMRI (Red). (B) Arcuate fascicle 
reconstruction and language areas and their relation to the neoplastic lesion. (C) 3D reconstruction of arcuate 
fascicle (Yellow), language areas (Red), and neoplastic lesion (Cyan).
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substances to dilate the vascular bed and cause a deoxygenated hemoglobin wash. 
Another consideration is that BOLD fMRI does not directly measure neural activity 
but changes in the region’s hemodynamic properties. So, the variability between 
functional localization among subjects may result from physiological differences in 
the BOLD signal without differences in neuronal activity per se. It has been found 
that several pharmacological agents may influence the BOLD signal [24].
2.5 The utility of fMRI and DTI in presurgical planning
The use of fMRI in conjunction with DTI for presurgical planning is currently 
the most established clinical application of these neuroimaging techniques. The aim 
is to provide the surgeon with functional information about the tumor’s area and its 
connections to adjacent areas. The regions of interest can be defined anatomically. 
However, the advance of functional imaging techniques allows us to define white 
matter tracts more precisely. Some reports mention that it is reliable in healthy ones 
but maybe inaccurate in those who harbor brain injuries Figure 3 [21].
3. Nuclear medicine for imaging brain tumors
In Mexico, PET positron emission tomography equipment began with opening 
the PET-Cyclotron Unit of the National Autonomous University of Mexico in 2002. 
We use nuclear medicine to determine the degree of malignancy of the lesions, 
evaluate the response to treatment, identify early recurrence, and radiotherapy 
planning.
By obtaining functional information of cellular and biological processes like glu-
cose metabolism, protein synthesis, the PET with 18 fluoro-deoxy-glucose (FDG) 
PET was initially used to detect and distinguish tumors of a low and high degree 
of malignancy. 18 Fluoro-ethyl-tyrosine (18 F FET) evaluates the metabolism of 
amino acids. It provides well-contrasted images in both high and low-grade tumors. 
It is beneficial to take biopsies guided by image to establish a primary brain tumor 
diagnosis in the planning of radiotherapy treatments and distinguish between 
tumor recurrence or radionecrosis after initial therapy Figure 4 [4].
It has a sensitivity of 94% and specificity of 88% for the diagnosis of brain 
tumors. Although the 18-FDG and 18-FET quantitative parameters allow the 
Figure 4. 
MRI and PET/CT 18F -FET fusion for brain tumor recurrence resection.
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distinction between low and high-grade tumors, only the 18-F FET values can 
distinguish between tumor and non-tumor lesions, confirming the superiority of 
18-F FET over 18 FDG for the characterization of brain lesions. Since 18-FDG is 
unreliable for predicting the neoplastic nature due to absorption by inflammatory 
lesions, amino acid tracers such as FET have been developed in recent decades to 
increase specificity. However, to date, only a few studies limited to small population 
of patients compared the diagnostic value of 18-FDG and 18-FET. Goldman and 
Pirotte thoroughly reviewed the clinical management, images, and PET role [25].
Figure 5. 
The utility of Multimodal Neuronavigation for brain tumor resection. A 15-years-old girl was received with 
a history of left hemiparesis and tonic–clonic seizures. MRI was performed, and a low-grade glioma was 
suspected. DTI sequences were obtained. A PET-CT 18F-FET was obtained, and fusion with structural and 
DTI images was performed at the Brainlab workstation. (A) Structural MRI, 18F-FET PET-CT, and DTI for 
pyramidal tract were fused during neuronavigation planning. (B) Right, Transoperative 3D ultrasonographic 
images were obtained and fused with the previous neuronavigational plan. Left, Histopathological analysis 




On average, glioblastoma multiforme and medulloblastoma had a uniform and 
intense uptake throughout the tumor, while brainstem gliomas had a low uptake 
in less than 50% of the tumor and ependymoma had a low uptake throughout the 
tumor. When more than 50% of the tumor had uptake, the apparent diffusion 
coefficient was lower, which agrees with the increase in cellularity. In refractory/
recurrent brain gliomas, the low correlation between uptake and enhancement is 
associated with decreased patient survival. It may reflect concurrent tissue deg-
radation in the disease sites that received treatment and the development of new 
malignancy sites characterized by increased uptake of 18-F-FDG [26, 27].
The PET/MRI fusion tool in evaluating postoperative and radiooncological 
treatments provides information for tumor response, progression, and necrosis by 
radiation, affording the patients’ oncological and functional prognosis Figure 5.
4. Neuronavigation principles
Neuronavigation systems provide intraoperative guidance to the surgeon. 
Nevertheless, its real advantage is also to help them plan a proper surgical approach 
to avoid injury and incorporates functional data provided by preoperative images 
of magnetic resonance imaging, nuclear medicine, intraoperative sonographic 
studies, and in some places, magnetoencephalography (MEG) to prevent damage to 
eloquent areas during brain surgery [1].
Image-guided neuronavigation uses the principle of stereotaxy. The brain is 
considered a geometric entity divided into three imaginary spatial planes that 
intersect, orthogonal to each other (axial, coronal, and sagittal). Theoretically, any 
point within the brain is designated by a specific series of coordinates in each plane.
Neuronavigation platforms provide the unique opportunity to translate the 
two-dimensional information obtained from several imaging techniques – CT scan, 
MRI, fMRI, PET-CT, into 3D information in the patient’s brain of a computational 
interface at the operating room [16]. The predefined targets on the navigational 
plan increase the chance to perform a safe and functional gross total resection of 
malignant primary brain tumors.
Its main objective is to facilitate the extensive resection of the lesion, minimize 
the risk of neurological sequelae, and favor the prognosis of survival. After register-
ing the patient, the system’s accuracy is checked by identifying constant anatomical 
references or craniometric points. The contour of the lesion and the functional data 
are fused on the reference structures. In some cases, it is possible to transfer the 
images to the surgical microscope’s eyepieces during surgery.
The intraoperative accuracy of neuronavigation can be affected by changes in 
intracranial volume caused by tumor resection, brain inflammation, and cerebro-
spinal fluid flow Figure 1. Nevertheless, transoperative images can be combined 
with ultrasound, tomography, or magnetic resonance images. The intraoperative 
images offer the possibility of evaluating the residual tumor volume as the surgery 
progresses Figure 6.
4.1 DTI and fMRI in functional neuronavigation
Neuronavigation is currently applied in brain surgery, and it is a regular techno-
logical resource to increase safety in most neurosurgical procedures (27).
The functional navigation was described as a technological tool for brain tumor 
resection. It results from the merging of structural, DTI, and BOLD information 
concerning a malignant tumor’s localization. It allows us to know the precise loca-
tion of functional areas in the human brain [28].
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Clinical articles have suggested that the brain shift observed after the opening 
of the dura and cerebrospinal fluid depletion is the main disadvantage for neuro-
navigation precision. Nevertheless, several reports suggest that intraoperative MRI 
use can solve this consequence of brain displacement satisfactorily [29]. In our 
country, these facilities are not available. To solve it, we correct the brain shit with 
Figure 6. 
3D intraoperative ultrasonographic reconstruction increases the usefulness of multimodal neuronavigation for 
brain tumor resection. A 17-years-old boy with a history of neurofibromatosis type 1 arrives at the emergency 
department with a headache and left hemiparesis. On an MRI study, a glioblastoma multiforme was suspected. 
(A) MRI T1-enhanced Gd images acquired for surgery planning at (B) Brainlab workstation. (C) 3D 
ultrasonographic acquisition to fusion with predefined neuronavigation’s plan to achieve a gross total resection. 
(D) Immediate postoperative CT Scan.
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three-dimensional ultrasound (3D-US) scans before the dural opening, after the 
dural opening, and at the end of the resective surgery. Taking advantage of merg-
ing this new 3D-US information with previously developed navigation plans with 
information on the different modalities of structural, functional, and metabolic 
information tumor and the neighboring tissue. In order to preserve and restore the 
functional status of each patient. Some limitations to consider for applying these 
techniques are the biological variability among individuals, the displacement of 
deep brain structures, and the previously mentioned brain-shift.
5. Neuronavigation and intraoperative electrical stimulation
Prof. Hugues Duffau considers the brain as an entirely eloquent organ; every 
millimeter of the cerebral cortex represents, sometimes a well-recognized function, 
and others the association area for several complex functions as language and his 
diverse characteristics that sometimes define a person, visuospatial perception, 
auditive integration, and so forth.
In the pediatric patient, the patient’s age determines a more complex scenario 
because the stage of neurodevelopment at the time of brain tumor surgery deter-
mines the functions’ profile to evaluate. Some functions depend on the correct 
integration of cortical and subcortical areas in the developing brain. Thus, the 
extensive evaluation and integration in neuronavigation devices of structural, 
functional, and metabolic imaging techniques are essential to reduce the chance to 
produce functional sequels.
Undoubtedly, DTI has contributed substantially to the intraoperative identifica-
tion of withe matter tracts. Perhaps the most studied are those related to motor 
function. It has been widely described that subcortical continuous monopolar 
stimulation can help identify the pyramidal pathway with a comprehensive concor-
dance with its counterpart visualized by DTI.
Transoperative electrical stimulation is one more of the resources available to 
promote extensive glioma resection. The purpose is to preserve the patient’s func-
tionality while attempting to dry out as much of the injury as possible [30].
In our experience, the integration of neuronavigation with intraoperative 
electrical stimulation and brain mapping considerably reduces the risk of lesions 
secondary to brain tumor resection.
Monopolar continuous stimulation seems to be the most useful and reproduc-
ible procedure for the pyramidal tract’s subcortical characterization. With the aid 
of DTI, it is possible to identify the modifications preoperatively in the trajectory, 
density, and resultant distortion secondary to a CNS malignancy. The neuronavi-
gation plan defines precisely the location of the pyramidal tract. In the operative 
field, the neuronavigation tools and the intraoperative monopolar stimulation can 
effectively identify its location at subcortical, thalamic, and peduncular regions.
Recently advances suggest that intraoperative acquisition of DTI images can 
reduce the risk of sequelae.
6. Conclusions
The current neuronavigational technologies allow us to reach deep regions inside 
the human brain without an increased risk of disability.
The interrelation of different radiological information modalities – structural, 
functional, and metabolic, in the planning phase of the case and during the surgi-
cal procedure permit us to increase the gross-total resection rate for brain tumor 
resection.
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The integration of neurophysiological information into the neuronavigational 
platform during the neurosurgical procedure reduces complications by monitoring 
and stimulating withe matter tracts related to language and motor functions.
All multidisciplinary effort is directed to increase surgical techniques’ safety to 
benefit the quality of life of children who suffer from brain tumor disease.
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